Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation.
Saved in:
| Title: | Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation. |
|---|---|
| Authors: | Saultz JN; Division of Hematology/Oncology, Oregon Health & Sciences University Portland, Oregon. Electronic address: saultzje@ohsu.edu., Bolon YT; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, Minnesota., Wang T; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin., Spellman SR; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, Minnesota., Lee SJ; Fred Hutchinson Cancer Center, Seattle, Washington., He M; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, Minnesota., Camacho-Bydume C; Hackensack University Medical Center, Hackensack, New Jersey., Krishna C; Broad Institute of MIT, Harvard Cambridge, Massachusetts., Chowell D; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Shaffer BC; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York., Hsu KC; Weill Cornell Medical College, New York, New York; Immunology Program, Sloan Kettering Institute for Cancer Research, New York, New York., Paczesny S; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina., Gadalla SM; Division of Cancer Epidemiology and Genetics, National Institutes of Health, National Cancer Institute, Clinical Genetics Branch, Rockville, Maryland., Marsh SGE; University College London Cancer Institute, Royal Free Campus, London, United Kingdom., Betts BC; Roswell Park Cancer Institute, Buffalo, New York., Arrieta-Bolaños E; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2026 Apr; Vol. 32 (4), pp. 434.e1-434.e11. Date of Electronic Publication: 2025 Dec 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
